K. H. Lee

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

D-Y. Oh, S-A Im, S.R. Park et al. · British Journal of Cancer · 2009 · 138 citations · Full text

Medicine, Oncology, Pharmacology +17

Proteins involved in DNA damage response pathways and survival of stage I non-small-cell lung cancer patients

Chang‐Min Choi, Seok‐Chul Yang, Hang Joon Jo et al. · Annals of Oncology · 2012 · 25 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients

Young Hwan Park, J. J. Lee, Min‐Hee Ryu et al. · Annals of Hematology · 2006 · 19 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Palliative Chemotherapy Preferences and Factors that Influence Patient Choice in Incurable Advanced Cancer

Min Kyoung Kim, J.-L. Lee, M.S. Hyun et al. · Japanese Journal of Clinical Oncology · 2008 · 16 citations · Full text

Medicine, Oncology, Chemotherapy +16